EGFRvIII peptide (PEPvIII) (TFA)
EGFRvIII peptide (PEPvIII) TFA is a tumor-specific mutation that is widely expressed in glioblastoma multiforme (GBM) and other neoplasms and its expression enhances tumorigenicity. EGFRvIII peptide TFA represents a truly tumor-specific target for antitumor immunotherapy[1].
Product Specifications
UNSPSC
12352209
Target
EGFR
Type
Peptides
Related Pathways
JAK/STAT Signaling; Protein Tyrosine Kinase/RTK
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/egfrviii-peptide-pepviii-tfa.html
Purity
98.73
Solubility
H2O : 35.4 mg/mL (ultrasonic; warming)
Smiles
Molecular Formula
C72H112F3N19O26S
Molecular Weight
1748.83
References & Citations
Shipping Conditions
Blue Ice
Storage Conditions
-80°C, 2 years; -20°C, 1 year (Powder, sealed storage, away from moisture and light, under nitrogen)
Scientific Category
Peptides
Clinical Information
No Development Reported
Available Sizes
Explore Other Products
Browse additional items from our catalog